Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm - Wabbels, B; Reichel, G; Fulford-Smith, A; Wright, N; Roggenkämper, P (J Neural Transm (Vienna), 2011)